Related Experiment Video
Updated: Jun 24, 2026

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
Halofantrine Upregulates ATP6V0D2 and Induces Cytotoxic Autophagy in GBM Models
Ni Huang1,2,3, Ke Tang4,5,6,7, Guo-Qi Liu1,2,3
1Clinical Pharmacy and Pharmacology Research Institute, The Guilin Medical University, Guilin, 541001, Guangxi, China.
The antimalarial drug halofantrine (halo) shows potential against Glioblastoma (GBM). Halo upregulates ATP6V0D2, inducing cytotoxic autophagy and inhibiting GBM growth in vitro and in vivo.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.
- Halofantrine (halo), an antimalarial drug, has emerged as a potential therapeutic agent for GBM.
- Understanding the mechanism of halo's action in GBM is crucial for its clinical application.
Purpose of the Study:
- To investigate the inhibitory effect of halofantrine (halo) on Glioblastoma (GBM) cells.
- To elucidate the underlying molecular mechanism, focusing on the role of ATP6V0D2 and autophagy.
- To evaluate the therapeutic potential of halo against GBM in preclinical models.
Main Methods:
- Analysis of ATP6V0D2 expression in GBM using The Cancer Genome Atlas (TCGA) and patient samples.
- In vitro studies using U251 GBM cells to assess halo's effect on cell viability, ATP6V0D2 expression, and autophagy.
- Quantitative PCR, Western blot, immunofluorescence, and transmission electron microscopy were employed to analyze molecular and cellular changes.
- Construction of stable ATP6V0D2 knockdown and overexpression models in U251 cells.
- In vivo evaluation of halo's anti-tumor efficacy and mechanism in a U251 cell xenograft mouse model.
Main Results:
- ATP6V0D2 expression was found to be low in GBM patients.
- Halofantrine (halo) treatment upregulated ATP6V0D2 expression and induced cytotoxic autophagy (TA) in U251 cells.
- Knockdown of ATP6V0D2 inhibited halo-mediated autophagy and cytotoxicity, while overexpression enhanced these effects.
- Halo demonstrated significant anti-GBM activity in vivo, consistent with in vitro findings.
- ATP6V0D2 was identified as a key tumor suppressor factor in GBM.
Conclusions:
- Halofantrine (halo) exerts anti-GBM effects by upregulating ATP6V0D2 and promoting cytotoxic autophagy.
- ATP6V0D2 plays a critical role in mediating halo's anti-tumor activity in GBM.
- Further research is needed to assess halo's blood-brain barrier permeability and potential cardiac toxicity.
More Related Videos
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
11:21Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015